可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:
[1]Dias VC, Weir SJ , Ellenbogen KA.Pharmacokinetics and pharmacodynamics of intravenous diltiazem in patients with atrial fibrillation or atrial flutter.Circulation, 1992; 86: 1421.
[2]Ellenbogen KA , Dias VC, Plumb VJ , et al.A placebocontrolled trial of continuous intravenous diltiazem infusion for 24 hour heart rate control during atrial fibrillation and atrial flutter: a multicenter study.J Am Coll Cardiol, 1991; 18: 891.
[3]Ellenbogen KA , Dias VC, Cardell FP, et al.Safety and efficacy of int ravenous diltiazem in at rial fibrillation or atrial flutter.Am J Cardiol, 1995; 75: 45.
[4]Goldenberg IF, Lewis WR, Dias VC, et al.Intravenous diltiazem for the treatment of patients with atrial fibrillation or flutter and moderate to severe congestive heart failure.Am J Cardiol, 1994; 74: 884.